140 related articles for article (PubMed ID: 28060692)
1. [Pharmacy Medicines Not Subject to Medical Prescription in Portugal: An Underused Access Opportunity?].
Martins AP; Gonçalves E; Marcelo A; Vilão S; Aranda Silva J
Acta Med Port; 2016 Sep; 29(9):542-548. PubMed ID: 28060692
[TBL] [Abstract][Full Text] [Related]
2. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacy Medicines not Subject to Medical Prescription: Compatible Access and Security].
Paulino E
Acta Med Port; 2016 Sep; 29(9):495-496. PubMed ID: 28060684
[No Abstract] [Full Text] [Related]
4. Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand.
Shaw JP; Gauld N; Kelly F
Int J Pharm Pract; 2016 Feb; 24(1):6-12. PubMed ID: 26154432
[TBL] [Abstract][Full Text] [Related]
5. Why does increasing public access to medicines differ between countries? Qualitative comparison of nine countries.
Gauld N; Bryant L; Emmerton L; Kelly F; Kurosawa N; Buetow S
J Health Serv Res Policy; 2015 Oct; 20(4):231-9. PubMed ID: 26152909
[TBL] [Abstract][Full Text] [Related]
6. Medicines reclassification from a pharmaceutical industry perspective: An international qualitative study.
Gauld NJ; Kelly FS; Emmerton LM; Kurosawa N; Bryant LJM; Buetow SA
Res Social Adm Pharm; 2019 Apr; 15(4):387-394. PubMed ID: 30917892
[TBL] [Abstract][Full Text] [Related]
7. Australian pharmacy perspectives on increasing access to medicines through reclassification.
Mey A; King M; Kelly F; Grant G; Townshend J; Baumann-Birkbeck L; Woods P; Hope D
J Health Serv Res Policy; 2019 Apr; 24(2):81-90. PubMed ID: 30352516
[TBL] [Abstract][Full Text] [Related]
8. Analysing the landscape for prescription to non-prescription reclassification (switch) in Germany: an interview study of committee members and stakeholders.
Gauld NJ
BMC Health Serv Res; 2019 Jun; 19(1):404. PubMed ID: 31221154
[TBL] [Abstract][Full Text] [Related]
9. Non-prescription medicines: current issues in Australian community pharmacy.
Tan AC; Emmerton L
Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
[TBL] [Abstract][Full Text] [Related]
10. [Effects of health-service reform in the field of medicinal drugs I. Analysis from the standpoint of a pharmacy].
Macesková B; Streitová J
Ceska Slov Farm; 2011 Jun; 60(3):99-104. PubMed ID: 21838138
[TBL] [Abstract][Full Text] [Related]
11. Australian pharmacists: ready for increased non-prescription medicines reclassification.
Hope DL; Woods P; Mey A; Kelly FS; Townshend J; Baumann-Birkbeck LM; King MA
Int J Pharm Pract; 2020 Jun; 28(3):246-254. PubMed ID: 31913550
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
[TBL] [Abstract][Full Text] [Related]
13. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries.
Vogler S; Habimana K; Arts D
Health Policy; 2014 Sep; 117(3):311-27. PubMed ID: 24962537
[TBL] [Abstract][Full Text] [Related]
14. Medicinal Product Regulation: Portugal׳s Framework.
Herdeiro MT; Bastos PD; Teixeira-Rodrigues A; Roque F
Clin Ther; 2016 Sep; 38(9):2118-2126.e2. PubMed ID: 27574988
[TBL] [Abstract][Full Text] [Related]
15. Television advertising of pharmacy medicines in the United Kingdom.
John DN; Evans SW
Pharm World Sci; 2000 Aug; 22(4):136-9. PubMed ID: 11103383
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical counseling: Between evidence-based medicine and profits.
Egorova SN; Akhmetova T
Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
[TBL] [Abstract][Full Text] [Related]
17. General sale of non-prescription medicinal products: Comparing legislation in two European countries.
Lind J; Schafheutle E; Hägg AN; Sporrong SK
Res Social Adm Pharm; 2016; 12(1):68-77. PubMed ID: 25842184
[TBL] [Abstract][Full Text] [Related]
18. Quality supply of nonprescription medicines in Portuguese community pharmacy: An exploratory case study.
Veiga P; Lapão LV; Cavaco AM; Guerreiro MP
Res Social Adm Pharm; 2015; 11(6):880-90. PubMed ID: 25662595
[TBL] [Abstract][Full Text] [Related]
19. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
Emmerton L
J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of brand names of medicines: linguistic and format issues.
Pires C; Cavaco A; Vigário M
Int J Pharm Pract; 2017 Jun; 25(3):231-237. PubMed ID: 27677527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
